UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 10
October-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2310684


Registration ID:
527212

Page Number

h678-h682

Share This Article


Jetir RMS

Title

Dawa ul Kurkum: An Innovative Hepato-protective Unani Formulation: A Review

Abstract

Abstract : Liver disease refers to an inflammatory and pathological condition which may be due to viral infection, autoimmune hepatitis and hepatitis that occurs as a secondary result of medications, drugs, toxins, and alcohol. Autoimmune hepatitis is a disease that occurs when your body makes antibodies against your liver tissue. If symptoms occur with an acute infection, they can appear anytime from two weeks to six months after exposure. Symptoms manifested by fever, fatigue, nausea, vomiting, abdominal pain, anorexia, dyspepsia, irregularity in bowel habits, dull ache in hepatic region, Jaundice, dark urine, light-colored stools Hepatitis, Cirrhosis, Ascites, Haemochromatosis, Hepatic failure etc . In view of high prevalence and absence of any approved therapies, this review was an attempted to explore the efficacy and safety of Dawa-ul-Kurkum in liver disease. Dawa-ul-Kurkum has potential to reduce the symptoms and grading of Hepatic dysfunctions, Anaemia, Ascitis, inflammation of Liver and spleen. There was no any adverse effect observed while using formulation. Hence it can be concluded that the drug Dawa-ul-Kurkum is effective and safe in the management of hepatic dysfunction and it is a novel remedy for the management of liver diseases. It was observed that after different clinical studies, Anorexia, Nausea, Dyspepsia and Heaviness in right hypochondriac region were significantly reduced and drug is effective in relieving symptoms, reduction in body weight and dull ache and dissolving fat from hepatocyte. Ultrasonography of patients shows grade I fatty liver and no patient remains in grade II fatty liver though its results on liver enzymes and lipid profile were insignificant statistically. The safety profiles of Dawa ul Kurkum were evaluated after laboratory investigations which include Complete blood count, Hb%, ESR, Blood Urea, S. Creatinine, SGOT, SGPT, and Alkaline Phosphatase shows significant difference. IndexTerms - Dawa-ul-Kurkum; Hepatic dysfunctions; Anorexia; Unani Medicine; liver disease.

Key Words

Dawa-ul-Kurkum; Hepatic dysfunctions; Anorexia; Unani Medicine; liver disease.

Cite This Article

"Dawa ul Kurkum: An Innovative Hepato-protective Unani Formulation: A Review ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 10, page no.h678-h682, October-2023, Available :http://www.jetir.org/papers/JETIR2310684.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Dawa ul Kurkum: An Innovative Hepato-protective Unani Formulation: A Review ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 10, page no. pph678-h682, October-2023, Available at : http://www.jetir.org/papers/JETIR2310684.pdf

Publication Details

Published Paper ID: JETIR2310684
Registration ID: 527212
Published In: Volume 10 | Issue 10 | Year October-2023
DOI (Digital Object Identifier):
Page No: h678-h682
Country: Dewas, Madhya Pradesh , India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00082

Print This Page

Current Call For Paper

Jetir RMS